Medical Properties Trust, Inc. (MPW): Is This High Yield Dividend Stock a Good Buy Right Now?

We recently compiled a list of the 10 Very High Yield Dividend Stocks With Upside Potential. In this article, we are going to take a look at where Medical Properties Trust, Inc. (NYSE:MPW) stands against the other stocks with over 8% dividend yield.

High yields have always sparked debate between analysts and investors. Analysts typically advise caution with extremely high yields, while investors often find them attractive. Analysts' concerns are valid; high yields can sometimes be warning signs of financial instability within a company. Many companies offering exceptionally high yields have been on the brink of cutting or suspending their dividends. That said, no company is completely out of the woods regarding its challenges, and dividend yield plays a minor role in a company's financial difficulties. In fact, many reports have highlighted that high-yield stocks have performed well over the years.

Newton Investment Management published a report revealing that high-yield dividend stocks outperformed the broader market during high inflationary periods from 1940 to 2021. The report also showed that investment portfolios with high-yield dividend stocks outperformed those with low or no dividend stocks in terms of value-weighted performance. High-yield portfolios outpaced low-yield ones by 199 basis points and zero-yield portfolios by 330 basis points. This outcome is informative, yet it does not provide insights into the market conditions of that time, offering only a general overview of high-yield stock performance. Analysts have been particularly attentive to how dividend stocks perform during periods of market volatility, recognizing that the demand for regular income is most keenly felt during these times. Therefore, analysts recommend considering stocks with high yields only if these companies also demonstrate strong dividend growth streaks.

The S&P High Yield Dividend Aristocrat Index seeks to track the performance of companies with at least 20 consecutive years of dividend growth with an average dividend yield of 3%. According to a report by S&P Dow Jones Indices, in a backdrop of slowing growth but rising inflation, the index achieved a monthly average total return of 0.39% from 1999 through April 2024, surpassing the benchmark by approximately 120 basis points. Historically, inflationary environments have typically benefited short-duration stocks like Dividend Aristocrat companies. During slow growth phases with declining inflation, the performance of the High Yield Dividend Aristocrats has aligned closely with the benchmark. The report further mentioned that the dividend growth rate for the index also surpassed inflation over the long term.

As mentioned above, when investing in dividend stocks, high yield and dividend growth must go hand in hand, as many companies have shown that it is indeed possible. Analysts typically view yields between 3% to 7% as healthy. The health of dividend stocks is often assessed based on their ability to generate cash flow and their track record of dividend growth. Investors favor stocks that not only offer high yields but also maintain or steadily increase their dividend payouts, rather than frequently cutting them. Examples include some of the best dividend stocks such as Altria Group, Inc., Verizon Communications Inc., and British American Tobacco p.l.c. that have above-average dividend yields coupled with robust dividend growth histories. To read more about strong dividend payers, have a look at Best Blue Chip Dividend Stocks To Buy.

Our Methodology:

For this list, we screened for dividend stocks with yields higher than 8% as of July 8. Then, we narrowed down the choices by finding stocks with an upside potential according to analyst predictions. Finally, we selected companies with the most hedge fund investors holding stakes in them, using Insider Monkey's Q1 2024 database. The stocks are ranked in ascending order of hedge fund investors having stakes in them. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points. (see more details here).

A real estate CEO pointing to a hospital facility on a financial chart.

Medical Properties Trust, Inc. (NYSE:MPW)

Number of Hedge Fund Holders: 18

Dividend Yield as of July 8: 14.55%

Medical Properties Trust, Inc. (NYSE:MPW) is an Alabama-based real estate investment trust company that mainly invests in healthcare facilities. The company has expanded over the years and developed into one of the largest owners of hospital real estate globally. It faced significant challenges last year due to its tenant, Steward Health, filing for bankruptcy. In addition, after more than a decade of consistent dividend growth, the company was forced to cut its dividend last year. That said, the company has managed to overcome these challenges. In response to its tenant's bankruptcy, the company approved $75 million in debtor-in-possession financing. It has not pledged any further funding beyond this amount. The company anticipates that Steward will use the financing to maintain patient care continuity while speeding up the process of transferring hospital operations to new operators.

Despite the challenges, analysts view the stock as an opportunity. The bankruptcy of its tenant, while a current issue, presents a potential upside. With Steward Health putting all its hospitals up for sale, a successful sale could lead Medical Properties Trust, Inc. (NYSE:MPW) to secure financially stable tenants, turning the situation into a hidden blessing. Street analysts have a consensus $4.88 price target on the stock, showing an upside potential of over 18%.

Funds from Operations (FFO) is the main metric for REITs because it provides a more accurate measure of the company's operating performance than traditional net income. Despite experiencing losses, Medical Properties Trust, Inc. (NYSE:MPW) reported a positive FFO of $0.24 in the first quarter of 2024, which missed analysts' estimates by $0.01. The company's revenue for the quarter came in at $271.3 million, which showed a 22.5% drop from the same period last year. However, it has executed total liquidity transactions amounting to $1.6 billion year-to-date, achieving 80% of its initial target for FY24. In its earnings report, the company mentioned that it continues to implement a capital allocation strategy that is projected to surpass its initial target of $2 billion in liquidity transactions for 2024.

On May 30, Medical Properties Trust, Inc. (NYSE:MPW) declared a quarterly dividend of $0.15 per share, which was in line with its previous dividend. The stock's dividend yield on July 8 came in at 14.55%.

As of the close of Q1 2024, 18 hedge funds in Insider Monkey's database held stakes in Medical Properties Trust, Inc. (NYSE:MPW), worth collectively nearly $81 million. With more than 4 million shares, Silver Point Capital was the company's leading stakeholder in Q1.

Overall MPW ranks 9th on our list of the best high yield dividend stocks with upside potential. You can visit 10 Very High Yield Dividend Stocks With Upside Potential to see the other high yield dividend stocks that are on hedge funds’ radar. While we acknowledge the potential of MPW as an investment, our conviction lies in the belief that some deeply undervalued dividend stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for a deeply undervalued dividend stock that is more promising than MPW but that trades at less than 7 times its earnings and yields nearly 10%, check out our report about the dirt cheap dividend stock.

 

READ NEXT: Analyst Sees a New $25 Billion “Opportunity” for NVIDIA and 10 Best of Breed Stocks to Buy For The Third Quarter of 2024 According to Bank of America.

 

Disclosure: None. This article is originally published at Insider Monkey.